CD38 as a prognostic marker in CLL
Author:
- 1 February 2005
- journal article
- review article
- Published by Taylor & Francis in Hematology
- Vol. 10 (1) , 39-46
Abstract
Cell-surface expression of CD38 in CLL has been recognised recently as a marker of progressive disease and poor outcome. In contrast to traditional staging systems, CD38 is able to identify progressive cases at an early stage. Measurement of CD38, in conjunction with other novel prognostic factors such as p53 and ZAP-70 helps to identify patients who might benefit from early and more intensive therapy. In addition, CD38 positivity can predict unmutated IgVH gene mutation status in most cases. These features, together with its easy applicability, render CD38 a valuable tool in the routine diagnostics of CLL. Questions remaining to be clarified about CD38 include the incidence and significance of its variations during the course of the disease, the optimal method to define CD38 positivity and the impact of different methodologies on results. Only after these issues are resolved can the definitive place of CD38 be defined in the diagnostics of CLL.Keywords
This publication has 60 references indexed in Scilit:
- The cycling history of CLLBlood, 2004
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progressionBlood, 2003
- Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 2002
- Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic LeukemiaJournal of Experimental Medicine, 2001
- Association of CD38 Antigen Expression with Other Prognostic Parameters in Early Stages of Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2001
- CD38 in Hematopoiesis2000
- Topology of CD382000
- Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia.Journal of Clinical Investigation, 1998
- A Single Protein Immunologically Identified as CD38 Displays NAD+ Glycohydrolase, ADP-Ribosyl Cyclase and Cyclic ADP-Ribose Hydrolase Activities at the Outer Surface of Human ErythrocytesBiochemical and Biophysical Research Communications, 1993